Idexx Laboratories IDXX Rebate and up-front considerations arrangements — Deferred revenue recognized
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Idexx Laboratories in its filing.
Tagged under the XBRL concept us-gaap:ContractWithCustomerLiabilityRevenueRecognized.
The official record: Idexx Laboratories’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Idexx Laboratories's rebate and up-front considerations arrangements — deferred revenue recognized.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Idexx Laboratories's rebate and up-front considerations arrangements — deferred revenue recognized?
- Idexx Laboratories (IDXX) reported rebate and up-front considerations arrangements — deferred revenue recognized of $2.5M in Q1 2026.
- How has Idexx Laboratories's rebate and up-front considerations arrangements — deferred revenue recognized changed year-over-year?
- Idexx Laboratories's rebate and up-front considerations arrangements — deferred revenue recognized decreased by 10.7% year-over-year, from $2.8M to $2.5M.
- What is the long-term trend for Idexx Laboratories's rebate and up-front considerations arrangements — deferred revenue recognized?
- Over 2 years (2023 to 2025), Idexx Laboratories's rebate and up-front considerations arrangements — deferred revenue recognized has grown at a -9.6% compound annual growth rate (CAGR), from $12.6M to $10.3M.
- What does rebate and up-front considerations arrangements — deferred revenue recognized mean?
- This metric represents the portion of deferred revenue from rebate and up-front arrangements that has been successfully recognized as revenue during the reporting period. It tracks the actual conversion of contractual liabilities into realized income as performance obligations are satisfied. This provides insight into the operational execution of the company's customer incentive and contract programs.